NCT03854929View on ClinicalTrials.gov

Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery

PHASE4CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

December 11, 2019

Primary Completion Date

February 6, 2021

Study Completion Date

July 12, 2022

Conditions
Dysentery, ShigellaShigellosisDiarrhea
Interventions
DRUG

Ciprofloxacin

"Fluoroquinolone, ATC code: J01MA02~DNA-gyrase and topoisomerase IV inhibitor"

DRUG

Azithromycin

"Macrolide, ATC code: J01FA10~Binds to ribosomal 50S sub-unit inhibiting translocation of peptides thereby suppressing bacterial protein synthesis."

Trial Locations (1)

70000

Children's Hospital 2, Ho Chi Minh City

All Listed Sponsors
collaborator

Number 2 Children's Hospital, Ho Chi Minh City

OTHER

collaborator

University of Liverpool

OTHER

lead

Oxford University Clinical Research Unit, Vietnam

OTHER

NCT03854929 - Ciprofloxacin Versus Azithromycin for Children Hospitalised With Dysentery | Biotech Hunter | Biotech Hunter